Campaign Finance$5,550 Given
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
- PAC Color Block
- Organization's PAC(s)
- Employee Color Block
- Associated Individuals
Republicans vs. Democratsin dollars
State vs. Federalin dollars
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Good Technology
Names of Lobbyists
Most Frequently Disclosed Lobbying Issues
- Homeland Security,
RegulationsMentioned in 9 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Good Technology" in public comments on proposed federal regulations.
Mentions in Document Text
View all mentions data for Good Technology
- Toggle 1 EPA Glyphosate – Pesticide Petition (PP# 2E7979) and Registration Requests for use on root and tuber vegetables, except sugarbeets; oilseed group 20; teff forage and hay; vegetable, bulb, group 3-07; vegetable, fruiting, group 8-10; fruit, citrus, group 10-10; fruit, pome, group 11-10; berry and small fruit, group 13-07 2012
- Toggle 1 BOEM Alaska Outer Continental Shelf Chukchi Sea Planning Area Oil and Gas Lease Sale 193 2011
- Toggle 1 EPA TX118 Texas Revisions to the New Source Review (NSR) State Implementation Plan (SIP); Antibacksliding of Major NSR SIP Requirements for the One-Hour Ozone National Ambient Air Quality Standards (NAAQS); Major Nonattainment NSR (NNSR) SIP Requirements for the 1997 Eight-Hour Ozone NAAQS; and Major NSR Reform Program 2011
- Toggle 1 CPSC Table Saw Blade Contact Injuries: Request for Comments and Information 2011
- Toggle 1 FDA Draft Guidance for Industry: Implementation of Acceptable Abbreviated Donor History Questionnaire and Accompanying Materials for Use in Screening Frequent Donors of Blood and Blood Components; Availability 2011
- Toggle 1 EPA Imperial Rule 425 submitted 7/20/10; Imperial Rule 427 submitted 7/20/10; SJV Rule 4602 submitted 5/17/10; SJV Rule 4603 submitted 5/17/10. 2011
- Toggle 1 FDA Town Hall Discussion with the Director of the Center for Devices and Radiological Health and Other Senior Center Management 2011
- Toggle 1 FDA Using Innovative Technologies and Other Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription 2012
- Toggle 1 APHIS Monsanto Co.; Availability of Petition for Determination of Nonregulated Status of Soybean GE'd for Dicamba Tolerance 2012